The Deal's 2nd half M&A scene: Interview with Spencer Klein, Morrison Foerster
Innovative Exit Strategies for Life Sciences Companies – Interview with Bill Whelan, Member, Mintz Levin
Financing Trends in Life Sciences – Interview with Bill Whelan, Member, Mintz Levin
PODCAST - Inside Law - Emerging Technology & Startup Companies
Digital Health: Where is the Action for Entrepreneurs?
Spencer Klein of Morrison Foerster sits with The Deal to talk about major mergers and acquisitions---and how private equity came to find itself on the sidelines.
For M&A, the second half of 2013 should pick up compared to...more
In This Survey:
- Survey Results
- Offerings Completed
- Size of Offering 2013, First Half
- Size of Offering 2011-2012
- Aggregate Amount Raised 2013, First Half
It used to take years to get an idea to market. But these days, the next "big thing" can be launched from your tablet or phone. Today's entrepreneurs have a whole host of business and legal issues to be aware of including...more
In This Issue:
- Activity Level of 2012 New England Transactions - All Rounds
- Activity Level of New England Seed Transactions
- Activity Level of New England Series A Transactions
We are pleased to provide a collection of commentaries on the critical legal issues facing our clients in 2013.
There is hope that global economic and market conditions will continue to improve despite ongoing...more
In This Issue:
Life Technologies Corp. et al. v. Kappos et al.; Abbvie Biotechnology, Ltd. v. Kappos; Human Genome Sciences, Inc. v. Kappos; and Shionogi & Co., Ltd. v. Sandoz Inc. ...more